Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cardiome Pharma Corp (CRME) since 2009 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Cardiome Pharma Corp. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1036141.
Total stock buying since 2009: $3,919,000.
Total stock sales since 2009: $9,028,000.
Total stock option exercises since 2009: $0.
▪ Recent SEC 13D filings for CRME
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
A schedule 13D must be filed with the SEC when a person or group of persons acquires beneficial ownership of more than 5% of Cardiome Pharma Corp (CRME). A schedule 13D/A is an amendment that is filed when there are any material changes in beneficial ownership.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2010 | 0 | $0 | 1,150,000 | $9,028,000 | 0 | $0 |
| 2009 | 1,000,000 | $3,919,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2010-04 | 0 | $0 | 1,150,000 | $9,028,000 | 0 | $0 |
| 2009-04 | 1,000,000 | $3,919,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-04-14 | Gross Phillip (10% Owner) | Sale | 650,000 | 7.92 | 5,148,000 |
| 2010-04-05 | Gross Phillip (10% Owner) | Sale | 500,000 | 7.76 | 3,880,000 |
| 2009-04-09 | Gross Phillip (10% Owner) | Buy | 1,000,000 | 3.92 | 3,919,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of CRME listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cardiome Pharma Corp (symbol CRME, CIK number 1036141) see the Securities and Exchange Commission (SEC) website.